{
  "CellLine_hpscreg_id": "HPIi006-A",
  "CellLine_alt_names": [
    "RYR1-3278-R2A"
  ],
  "CellLine_cell_line_type": "hiPSC",
  "CellLine_source_cell_type": "Lymphoblastoid cell line (LCL)",
  "CellLine_publication_doi": "10.1016/j.scr.2024.103410",
  "CellLine_publication_pmid": "",
  "CellLine_publication_title": "Generation of two iPSC lines from patients with inherited central core disease and concurrent malignant hyperthermia caused by dominant missense variants in the RYR1 gene",
  "CellLine_publication_first_author": "Joshua S. Clayton",
  "CellLine_publication_last_author": "Rhonda L. Taylor",
  "CellLine_publication_journal": "Stem Cell Research",
  "CellLine_publication_year": 2024,
  "CellLine_donor_age": 3,
  "CellLine_donor_sex": "Male",
  "CellLine_donor_disease_name": "Central core disease of muscle; CCD",
  "CellLine_donor_disease_description": "Central core disease (CCD) is a highly heterogeneous myopathy characterized histologically by the presence of centrally located core-like areas in skeletal muscle fibres that are depleted of mitochondria.",
  "CellLine_source_tissue": "Blood",
  "CellLine_source": "donor",
  "CellLine_contact_name": "Dr. Joshua Clayton",
  "CellLine_contact_email": "joshua.clayton@perkins.org.au",
  "CellLine_contact_phone": "",
  "CellLine_maintainer": "Harry Perkins Institute of Medical Research",
  "CellLine_producer": "Harry Perkins Institute of Medical Research",
  "CellLine_frozen": true,
  "GenomicAlteration_performed": true,
  "GenomicAlteration_mutation_type": "variant",
  "GenomicAlteration_cytoband": "",
  "GenomicAlteration_delivery_method": "transgene expression",
  "GenomicAlteration_loci_name": "Ryanodine Receptor 1, Skeletal Muscle (RYR1)",
  "GenomicAlteration_loci_chromosome": "",
  "GenomicAlteration_loci_start": 7522,
  "GenomicAlteration_loci_end": 7522,
  "GenomicAlteration_loci_group": "",
  "GenomicAlteration_loci_disease": "Central core disease of muscle; CCD",
  "GenomicAlteration_description": "Inherited variant (dominant, inherited from affected father)",
  "GenomicAlteration_genotype": "Heterozygous for RYR1 c.7522C > T variant (p.Arg2508Cys)",
  "PluripotencyCharacterisation_cell_type": "Mesoderm",
  "PluripotencyCharacterisation_shown_potency": true,
  "PluripotencyCharacterisation_marker_list": [
    "OCT4",
    "SOX2",
    "SSEA4",
    "TRA-1-60"
  ],
  "PluripotencyCharacterisation_method": "Immunocytochemistry and qRT-PCR",
  "PluripotencyCharacterisation_differentiation_profile": "in vitro directed differentiation",
  "ReprogrammingMethod_vector_type": "non-integrated",
  "ReprogrammingMethod_vector_name": "Sendai virus",
  "ReprogrammingMethod_kit": "CytoTune-iPS 2.0TM",
  "ReprogrammingMethod_detected": true,
  "GenomicCharacterisation_passage_number": 13,
  "GenomicCharacterisation_karyotype": "46, XY",
  "GenomicCharacterisation_karyotype_method": "G-Banding",
  "GenomicCharacterisation_summary": "At P13: 46, XY (normal male karyotype) with banding resolution of 400 bands per haploid set.",
  "STR_Results_exists": true,
  "STR_Results_loci": 22,
  "STR_Results_group": "Non-HLA",
  "STR_Results_allele_1": "",
  "STR_Results_allele_2": "",
  "InducedDerivation_i_source_cell_type": "Lymphoblastoid cell line (LCL)",
  "InducedDerivation_i_cell_origin": "Blood",
  "InducedDerivation_derivation_year": "2022",
  "InducedDerivation_vector_type": "non-integrated",
  "InducedDerivation_vector_name": "Sendai virus",
  "InducedDerivation_kit_name": "CytoTune-iPS 2.0TM",
  "Ethics": [
    {
      "ethics_number": "RA/4/20/1008",
      "approval_date": "",
      "institute": "University of Western Australia's Human Research Ethics Committee"
    }
  ],
  "MicrobiologyVirologyScreening_performed": true,
  "MicrobiologyVirologyScreening_hiv1": "",
  "MicrobiologyVirologyScreening_hiv2": "",
  "MicrobiologyVirologyScreening_hep_b": "",
  "MicrobiologyVirologyScreening_hep_c": "",
  "MicrobiologyVirologyScreening_mycoplasma": "Negative",
  "MicrobiologyVirologyScreening_other": "Sendai virus (SeV), Epstein Barr virus (EBV)",
  "MicrobiologyVirologyScreening_other_result": "Negative for SeV by RT-PCR, Negative for EBV by PCR",
  "CultureMedium_co2_concentration": 5,
  "CultureMedium_o2_concentration": 21,
  "CultureMedium_passage_method": "Enzymatically",
  "CultureMedium_base_medium": "RPMI-1640 medium",
  "CultureMedium_base_coat": "Matrigel\u00ae"
}